These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28760196)

  • 1. Effects of PEP-1-FK506BP on cyst formation in polycystic kidney disease.
    Jo HS; Eum WS; Park EY; Ko JY; Kim DY; Kim DW; Shin MJ; Son O; Cho SB; Park JH; Lee CH; Yeo EJ; Yeo HJ; Choi YJ; Youn JK; Cho SW; Park J; Park JH; Choi SY
    BMB Rep; 2017 Sep; 50(9):460-465. PubMed ID: 28760196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transduced PEP-1-FK506BP inhibits the inflammatory response in the Raw 264.7 cell and mouse models.
    Kim SY; Jeong HJ; Kim DW; Kim MJ; An JJ; Sohn EJ; Kang HW; Shin MJ; Ahn EH; Kwon SW; Kim DS; Cho SW; Park J; Eum WS; Choi SY
    Immunobiology; 2011 Jul; 216(7):771-81. PubMed ID: 21288594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of anti-inflammatory activity of PEP-1-FK506 binding protein by silk fibroin peptide.
    Kim DW; Hwang HS; Kim DS; Sheen SH; Heo DH; Hwang G; Kang SH; Kweon H; Jo YY; Kang SW; Lee KG; Park J; Eum WS; Cho YJ; Choi SY
    J Microbiol Biotechnol; 2012 Apr; 22(4):494-500. PubMed ID: 22534296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transduced PEP-1-FK506BP ameliorates atopic dermatitis in NC/Nga mice.
    Kim SY; Sohn EJ; Kim DW; Jeong HJ; Kim MJ; Kang HW; Shin MJ; Ahn EH; Kwon SW; Kim YN; Kwon HJ; Kim TY; Lee KS; Park J; Eum WS; Choi SY
    J Invest Dermatol; 2011 Jul; 131(7):1477-85. PubMed ID: 21430698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of exogenous kidney-specific Ngal attenuates progressive cyst development and prolongs lifespan in a murine model of polycystic kidney disease.
    Wang E; Chiou YY; Jeng WY; Lin HK; Lin HH; Chin HJ; Leo Wang CK; Yu SS; Tsai SC; Chiang CY; Cheng PH; Lin HJ; Jiang ST; Chiu ST; Hsieh-Li HM
    Kidney Int; 2017 Feb; 91(2):412-422. PubMed ID: 28341240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin-Linked Kinase Signaling Promotes Cyst Growth and Fibrosis in Polycystic Kidney Disease.
    Raman A; Reif GA; Dai Y; Khanna A; Li X; Astleford L; Parnell SC; Calvet JP; Wallace DP
    J Am Soc Nephrol; 2017 Sep; 28(9):2708-2719. PubMed ID: 28522687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AKT signaling promotes DNA damage accumulation and proliferation in polycystic kidney disease.
    Conduit SE; Davies EM; Ooms LM; Gurung R; McGrath MJ; Hakim S; Cottle DL; Smyth IM; Dyson JM; Mitchell CA
    Hum Mol Genet; 2020 Jan; 29(1):31-48. PubMed ID: 31625572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of PEP-1-FK506BP on dry eye disease in a rat model.
    Kim DW; Lee SH; Ku SK; Lee JE; Cha HJ; Youn JK; Kwon HY; Park JH; Park EY; Cho SW; Han KH; Park J; Eum WS; Choi SY
    BMB Rep; 2015 Mar; 48(3):153-8. PubMed ID: 24998262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transduced PEP-1-FK506BP ameliorates corneal injury in Botulinum toxin A-induced dry eye mouse model.
    Kim DW; Lee SH; Ku SK; Cho SH; Cho SW; Yoon GH; Hwang HS; Park J; Eum WS; Kwon OS; Choi SY
    BMB Rep; 2013 Feb; 46(2):124-9. PubMed ID: 23433117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of phospholipase D in modulating the MTOR signaling pathway in polycystic kidney disease.
    Liu Y; Käch A; Ziegler U; Ong AC; Wallace DP; Arcaro A; Serra AL
    PLoS One; 2013; 8(8):e73173. PubMed ID: 24009738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy induction promotes renal cyst growth in polycystic kidney disease.
    Lee EJ; Ko JY; Oh S; Jun J; Mun H; Lim CJ; Seo S; Ko HW; Kim H; Oh YK; Ahn C; Kang M; Kim MJ; Yoo KH; Oh GT; Park JH
    EBioMedicine; 2020 Oct; 60():102986. PubMed ID: 32949996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRAF3 delays cyst formation induced by NF-κB signaling.
    Sun L; Hu C; Zhang X
    IUBMB Life; 2017 Mar; 69(3):170-178. PubMed ID: 28185403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fenobam promoted the neuroprotective effect of PEP-1-FK506BP following oxidative stress by increasing its transduction efficiency.
    Ahn EH; Kim DW; Shin MJ; Jo HS; Eom SA; Kim DS; Park EY; Park JH; Cho SW; Park J; Eum WS; Son O; Hwang HS; Choi SY
    BMB Rep; 2013 Nov; 46(11):561-6. PubMed ID: 24152913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen synthase kinase-3β promotes cyst expansion in polycystic kidney disease.
    Tao S; Kakade VR; Woodgett JR; Pandey P; Suderman ED; Rajagopal M; Rao R
    Kidney Int; 2015 Jun; 87(6):1164-75. PubMed ID: 25629553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-catenin ablation exacerbates polycystic kidney disease progression.
    Conduit SE; Hakim S; Feeney SJ; Ooms LM; Dyson JM; Abud HE; Mitchell CA
    Hum Mol Genet; 2019 Jan; 28(2):230-244. PubMed ID: 30265301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTOR signaling in polycystic kidney disease.
    Ibraghimov-Beskrovnaya O; Natoli TA
    Trends Mol Med; 2011 Nov; 17(11):625-33. PubMed ID: 21775207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEP-1-FK506BP inhibits alkali burn-induced corneal inflammation on the rat model of corneal alkali injury.
    Kim DW; Lee SH; Shin MJ; Kim K; Ku SK; Youn JK; Cho SB; Park JH; Lee CH; Son O; Sohn EJ; Cho SW; Park JH; Kim HA; Han KH; Park J; Eum WS; Choi SY
    BMB Rep; 2015 Nov; 48(11):618-23. PubMed ID: 25817214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic advances in the treatment of polycystic kidney disease.
    Riella C; Czarnecki PG; Steinman TI
    Nephron Clin Pract; 2014; 128(3-4):297-302. PubMed ID: 25573484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pranlukast inhibits renal epithelial cyst progression via activation of AMP-activated protein kinase.
    Pathomthongtaweechai N; Soodvilai S; Chatsudthipong V; Muanprasat C
    Eur J Pharmacol; 2014 Feb; 724():67-76. PubMed ID: 24360935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mild reduction of food intake slows disease progression in an orthologous mouse model of polycystic kidney disease.
    Kipp KR; Rezaei M; Lin L; Dewey EC; Weimbs T
    Am J Physiol Renal Physiol; 2016 Apr; 310(8):F726-F731. PubMed ID: 26764208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.